FIELD: medicine.
SUBSTANCE: group of inventions relates to immunology, and relates to a combination of chlamydial vaccine. Vaccine consists of a recombinant adenoviral vector based on human fifth-type adenovirus serotype expressing the gene for the full-length structural protein CdsF of the chlamydia type III secretion system, and an emulsion containing recombinant structural protein rCdsF secretion system type III chlamydia and a combined adjuvant. Methods for producing a vaccine and methods for producing recombinant proteins for a combination vaccine is also proposed.
EFFECT: group of inventions provides for the induction of a protective immune response against a chlamydial infection in a subject.
14 cl, 30 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PSEUDO-ADENOVIRAL PARTICLE STRAIN EXPRESSING THE CHLAMYDIA TRACHOMATIS CHIMERIC GENE MBL-CT666, A METHOD FOR PREPARING IT, AN IMMUNOGENIC COMPOSITION FOR PROTECTION AGAINST HUMAN UROGENITAL CHLAMYDIOSIS | 2019 |
|
RU2721123C1 |
| IMMUNOGENE COMPOSITION ON BASIS OF ANTIGEN Chlamydia trachomatis (VERSIONS) AND ITS USE | 2004 |
|
RU2352356C2 |
| METHOD OF PRODUCING RECOMBINANT VACCINE | 2010 |
|
RU2444570C1 |
| COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSTICS OF CHLAMYDIA INFECTION | 2001 |
|
RU2410394C2 |
| NANOANTIBODIES BINDING CHLAMYDIA TRACHOMATIS ANTIGEN, METHOD OF INHIBITING INFECTION CAUSED BY CHLAMYDIA TRACHOMATIS | 2012 |
|
RU2487724C1 |
| IMMUNISATION AGAINST CHLAMYDIA TRACHOMATIS | 2002 |
|
RU2331435C2 |
| CHLAMYDIA SP VACCINES | 2014 |
|
RU2723046C2 |
| METHOD FOR SETTING SEROLOGICAL DIAGNOSIS OF ACTIVE CHLAMYDIA INFECTION IN PREGNANT WOMEN | 2004 |
|
RU2272293C1 |
| SET FOR DETECTING CHLAMYDIAL INFECTION | 1992 |
|
RU2042360C1 |
| IMMUNOGENIC COMPOSITIONS OF MULTIPLE ANTIGEN PRESENTATION, METHODS AND APPLICATIONS RELATING THERETO | 2012 |
|
RU2619176C2 |
